Anti-CD19 Antikörper

Patent europeic · EP2216342 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2216342
Numer da la dumonda
EP10004495
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
02-08-2004
Publitgà
11-08-2010
Concedì
22-04-2015
Stritgà
02-08-2024
Motiv
Durada maximala cuntanschida
Classas IPC
C07K 16/28 (2006.01)
C12N 5/18 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 491282 P 31.07.2003
Derivà da
EP04779636
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 02-08-2024

    Durada maximala cuntanschida

    Published in Swissreg on 02.08.2024

  2. 01-09-2023

    Midada

    Published in Swissreg on 01.09.2023

  3. 01-09-2022

    Midada

    Published in Swissreg on 01.09.2022

  4. 17-07-2015

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 17.07.2015

  5. 22-04-2015

    Concedì

    Published in Swissreg on 22.04.2015

Partidas

Inventur

Hansen, Hans

Morris Plains, NJ 07950, US

Qu, Zhengxing

Morris Plains, NJ 07950, US

Goldenberg, David M.

Morris Plains, NJ 07950, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.